Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 60 and 90 years old
- People who are right-handed
- People whose first language is English
- People who score 25 points or above on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
- For people with hearing loss, a hearing test result showing an average hearing loss greater than 25 dB HL in the 1–4 kHz frequency range
Who may not be able to join:
- People who are left-handed, as brain response patterns differ from those of right-handed people
- People with a history of psychiatric or neurological conditions, including skull fractures, as these can affect brain signal readings
- People who score below 25 points on the MoCA memory and thinking test
- People who take certain prescription or non-prescription medications known to affect brain function or the nervous system, such as antidepressants or ADHD medications (confirm with trial site for a full list)
- People with an eye condition that would affect the ability to measure pupil size, such as cataracts, nystagmus, or amblyopia (lazy eye)
- People who score below 50% on a speech-listening control task, which may suggest difficulty understanding spoken words clearly enough for the study
- People whose behaviour during the study would significantly interfere with data collection or safety
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 801-581-5040
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
N400 amplitude; N400 latency; P600 amplitude; P600 latency; pupil dilation; Delayed Recognition Memory
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.